Free Trial

Mount Yale Investment Advisors LLC Has $859,000 Stock Position in MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

Mount Yale Investment Advisors LLC reduced its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 27.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,493 shares of the financial services provider's stock after selling 3,906 shares during the quarter. Mount Yale Investment Advisors LLC's holdings in MetLife were worth $859,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. APG Asset Management N.V. grew its stake in MetLife by 208.8% in the second quarter. APG Asset Management N.V. now owns 74,978 shares of the financial services provider's stock worth $4,910,000 after purchasing an additional 50,700 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in shares of MetLife by 9.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 727,832 shares of the financial services provider's stock worth $51,087,000 after buying an additional 64,070 shares in the last quarter. Scientech Research LLC purchased a new position in shares of MetLife during the second quarter valued at $264,000. Creative Planning lifted its stake in MetLife by 3.1% in the second quarter. Creative Planning now owns 127,003 shares of the financial services provider's stock worth $8,914,000 after acquiring an additional 3,865 shares during the period. Finally, NewEdge Advisors LLC grew its holdings in MetLife by 1.6% during the 2nd quarter. NewEdge Advisors LLC now owns 47,203 shares of the financial services provider's stock worth $3,313,000 after acquiring an additional 737 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.

MetLife Stock Performance

NYSE:MET traded down $1.24 during mid-day trading on Tuesday, reaching $85.73. The stock had a trading volume of 3,587,779 shares, compared to its average volume of 3,583,330. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The business has a 50 day simple moving average of $83.88 and a 200 day simple moving average of $80.22. MetLife, Inc. has a twelve month low of $64.61 and a twelve month high of $89.05. The firm has a market capitalization of $59.36 billion, a price-to-earnings ratio of 17.28, a PEG ratio of 0.65 and a beta of 1.07.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.54%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife's dividend payout ratio (DPR) is currently 43.95%.

Wall Street Analysts Forecast Growth

MET has been the topic of a number of recent research reports. TD Cowen increased their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a "buy" rating in a research note on Wednesday, November 27th. Barclays lifted their price target on MetLife from $90.00 to $96.00 and gave the company an "overweight" rating in a report on Monday, January 6th. StockNews.com downgraded MetLife from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. Wells Fargo & Company reduced their target price on shares of MetLife from $93.00 to $92.00 and set an "overweight" rating for the company in a report on Tuesday, January 14th. Finally, BMO Capital Markets started coverage on shares of MetLife in a research report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $90.46.

View Our Latest Stock Analysis on MetLife

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines